| 0.06% |
| 4 | CSS LLC/IL | 110K | $375K | +78.4% | 1.213% | 0.01% |
| 5 | DELTEC ASSET MANAGEMENT LLC | 83K | $283K | -7.6% | 0.914% | 0.04% |
| 6 | Rangeley Capital, LLC | 81K | $275K | +8.0% | 0.889% | 0.25% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 73K | $247K | +2.5% | 0.798% | 0.00% |
| 8 | BlackRock, Inc. | 55K | $187K | 0.0% | 0.602% | 0.00% |
| 9 | VANGUARD FIDUCIARY TRUST CO | 49K | $166K | +40.2% | 0.538% | 0.00% |
| 10 | GTS SECURITIES LLC | 30K | $103K | -3.8% | 0.332% | 0.00% |
| 11 | STATE STREET CORP | 25K | $86K | 0.0% | 0.278% | 0.00% |
| 12 | JANE STREET GROUP, LLC | 19K | $64K | — | 0.206% | 0.00% |
| 13 | CITADEL ADVISORS LLC | 16K | $53K | -31.4% | 0.171% | 0.00% |
| 14 | NORTHERN TRUST CORP | 16K | $53K | +51.3% | 0.171% | 0.00% |
| 15 | JBF Capital, Inc. | 14K | $49K | +8.4% | 0.158% | 0.01% |
| 16 | Cerity Partners LLC | 12K | $41K | 0.0% | 0.134% | 0.00% |
| 17 | BANK OF AMERICA CORP /DE/ | 10K | $35K | 0.0% | 0.114% | 0.00% |
| 18 | HighTower Advisors, LLC | 10K | $34K | 0.0% | 0.110% | 0.00% |
| 19 | INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 5K | $17K | 0.0% | 0.055% | 0.00% |
| 20 | Founders Capital Management | 2K | $6K | 0.0% | 0.018% | 0.00% |
| 21 | Vanguard Global Advisers, LLC | 1K | $4K | 0.0% | 0.011% | 0.00% |
| 22 | Connective Capital Management, LLC | 1K | $3K | 0.0% | 0.011% | 0.00% |
| 23 | Tower Research Capital LLC (TRC) | 726 | $2K | -7.5% | 0.008% | 0.00% |
| 24 | OSAIC HOLDINGS, INC. | 200 | $680 | 0.0% | 0.002% | 0.00% |
| 25 | Caitong International Asset Management Co., Ltd | 90 | $306 | +309.1% | 0.001% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in LSTA — a direct measure of their conviction.
| 9.09% |
| 0.25 pp |
| $2M |
| 21% |
| Q4 2024 | 23 | +0.0% | 9.34% | +0.12 pp | $2M | +1.5% |
| Q3 2024 | 23 | — | 9.22% | — | $2M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
3 institutions opened new positions in LSTA during Q2 2026, while 5 fully exited. 3 added to existing positions and 24 trimmed.
LSTA institutional ownership rose by 1.79 percentage points quarter-over-quarter, with a net change of -1 holders.
The top 10 institutions account for 88.5% of all reported 13F value in LSTA, and the top 25 account for 100.0%.
Across the largest Oncology Biotech peers, institutional ownership levels are: DMRA (200.0%), FTH (54.5%), LONA (184.4%), KYNB (26.9%), CNSY (4.8%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.